In consultation: Guidance and quality standards
Showing 11 to 12 of 12
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Leriglitazone for treating cerebral adrenoleukodystrophy in boys and men 2 years and over [ID3903] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292] | Draft guidance | Technology appraisal guidance |